scispace - formally typeset
A

Alexander Schmittel

Researcher at Charité

Publications -  103
Citations -  4815

Alexander Schmittel is an academic researcher from Charité. The author has contributed to research in topics: Cancer & Antigen. The author has an hindex of 38, co-authored 101 publications receiving 4535 citations. Previous affiliations of Alexander Schmittel include Free University of Berlin.

Papers
More filters
Journal ArticleDOI

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.

TL;DR: The most important new aspects included in this updated guideline include the newly published FIGO classification of 2018, the radical open surgery approach for cervical cancers up to FIGO stage IB1, and use of the sentinel lymph node technique for tumors.
Journal ArticleDOI

A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma

TL;DR: This first randomized trial in metastatic uveal melanoma showed a superior PFS and a trend for a higher response/stabilization rate of the GeT combination over T.
Journal ArticleDOI

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.

TL;DR: The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm.
Journal ArticleDOI

Medikamentöse Therapie des metastasierten Aderhautmelanoms

TL;DR: It is shown that chemoembolization and local chemotherapy are effective when only liver metastases are present and for patients with metastases in several organs, cytostatic combinations with gemcitabine and treosulfan are currently investigated in clinical studies.